Correlation Between Vor Biopharma and Tenaya Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Tenaya Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Tenaya Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Tenaya Therapeutics, you can compare the effects of market volatilities on Vor Biopharma and Tenaya Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Tenaya Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Tenaya Therapeutics.

Diversification Opportunities for Vor Biopharma and Tenaya Therapeutics

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vor and Tenaya is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Tenaya Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenaya Therapeutics and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Tenaya Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenaya Therapeutics has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Tenaya Therapeutics go up and down completely randomly.

Pair Corralation between Vor Biopharma and Tenaya Therapeutics

Considering the 90-day investment horizon Vor Biopharma is expected to generate 2.62 times more return on investment than Tenaya Therapeutics. However, Vor Biopharma is 2.62 times more volatile than Tenaya Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Tenaya Therapeutics is currently generating about -0.38 per unit of risk. If you would invest  112.00  in Vor Biopharma on November 2, 2024 and sell it today you would earn a total of  27.00  from holding Vor Biopharma or generate 24.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vor Biopharma  vs.  Tenaya Therapeutics

 Performance 
       Timeline  
Vor Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.
Tenaya Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tenaya Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Vor Biopharma and Tenaya Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vor Biopharma and Tenaya Therapeutics

The main advantage of trading using opposite Vor Biopharma and Tenaya Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Tenaya Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenaya Therapeutics will offset losses from the drop in Tenaya Therapeutics' long position.
The idea behind Vor Biopharma and Tenaya Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world